ES455294A1 - Un procedimiento de preparacion de una fenilamidina sustituida. - Google Patents

Un procedimiento de preparacion de una fenilamidina sustituida.

Info

Publication number
ES455294A1
ES455294A1 ES455294A ES455294A ES455294A1 ES 455294 A1 ES455294 A1 ES 455294A1 ES 455294 A ES455294 A ES 455294A ES 455294 A ES455294 A ES 455294A ES 455294 A1 ES455294 A1 ES 455294A1
Authority
ES
Spain
Prior art keywords
group
alkoxy group
amidines
substituted phenyl
oc2h5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES455294A
Other languages
English (en)
Spanish (es)
Inventor
Louis Lafon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of ES455294A1 publication Critical patent/ES455294A1/es
Priority to ES466887A priority Critical patent/ES466887A2/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES455294A 1976-01-26 1977-01-24 Un procedimiento de preparacion de una fenilamidina sustituida. Expired ES455294A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES466887A ES466887A2 (es) 1977-01-24 1978-02-10 Un procedimiento de preparacion de una fenilamidina substituida.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2895/76A GB1538097A (en) 1976-01-26 1976-01-26 Substituted phenyl-amidines

Publications (1)

Publication Number Publication Date
ES455294A1 true ES455294A1 (es) 1978-01-01

Family

ID=9748048

Family Applications (1)

Application Number Title Priority Date Filing Date
ES455294A Expired ES455294A1 (es) 1976-01-26 1977-01-24 Un procedimiento de preparacion de una fenilamidina sustituida.

Country Status (14)

Country Link
US (1) US4146647A (Direct)
JP (1) JPS5953895B2 (Direct)
BE (1) BE850723A (Direct)
CA (1) CA1074797A (Direct)
CH (1) CH620901A5 (Direct)
DE (1) DE2702119C2 (Direct)
DK (1) DK30277A (Direct)
ES (1) ES455294A1 (Direct)
FR (1) FR2338927A1 (Direct)
GB (1) GB1538097A (Direct)
IE (1) IE44416B1 (Direct)
LU (1) LU76641A1 (Direct)
NL (1) NL188573C (Direct)
SE (1) SE440501B (Direct)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630606A5 (en) * 1977-02-15 1982-06-30 Lafon Labor Phenylamidine derivatives useful especially in therapeutics
EP0011596B1 (de) * 1978-10-09 1981-12-30 Ciba-Geigy Ag Neue 2-(alpha-Phenoxy-alkyl)-imidazoline und ihre Salze, deren Herstellung und Verwendung sowie sie enthaltende Mittel zur Bekämpfung von pflanzenschädlichen und tierparasitären Milben
DE2965415D1 (en) * 1978-11-03 1983-06-16 Bayer Ag Anilinomethyloxime ethers and processes for their production
US4260626A (en) * 1979-03-26 1981-04-07 Richardson-Merrell Inc. Tetrahydro and imidazoline antisecretory compounds
US4616085A (en) * 1980-06-19 1986-10-07 Petrolite Corporation Thioethers of imidazolines
FR2506764A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives d'amidoximes, leur preparation et leur application en therapeutique
US5227484A (en) * 1982-01-14 1993-07-13 Merck Patent Gmbh Anisotropic compounds having nematic phase and liquid crystal mixtures
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
US4659363A (en) * 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
GB9509930D0 (en) * 1995-05-17 1995-07-12 Smithkline Beecham Corp Method for preparing certain acetonitriles
AU2007209381A1 (en) * 2006-01-27 2007-08-02 F. Hoffmann-La Roche Ag Use of substituted 2-imidazole of imidazoline derivatives
MX2009003887A (es) * 2006-10-19 2009-04-22 Hoffmann La Roche Aminometil-2-imidazoles con afinidad con los receptores asociados a trazas de amina.
KR101176699B1 (ko) * 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
CN101535292A (zh) * 2006-11-02 2009-09-16 弗·哈夫曼-拉罗切有限公司 作为痕量胺相关受体的调节剂的取代的2-咪唑类化合物
MX2009005047A (es) * 2006-11-16 2009-05-25 Hoffmann La Roche 4-imidazoles sustituidos.
ES2364701T3 (es) * 2006-12-13 2011-09-12 F. Hoffmann-La Roche Ag Nuevos 2-imidazoles como ligandos para receptores asociados a aminas trazas.
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
UA98951C2 (ru) * 2007-02-02 2012-07-10 Ф. Хоффманн-Ля Рош Аг 2-аминооксазолины и лекарственное средство, которое их содержит
ES2525229T3 (es) * 2007-02-15 2014-12-19 F. Hoffmann-La Roche Ag 2-aminooxazolinas como ligandos de TAAR1
JP2010531837A (ja) 2007-07-02 2010-09-30 エフ．ホフマン−ラ ロシュ アーゲー 微量アミン関連レセプター（ｔａａｒ）に対して良好な親和性を有する２−イミダゾリン
KR101150628B1 (ko) * 2007-07-03 2012-05-31 에프. 호프만-라 로슈 아게 4-이미다졸린 및 항우울제로서 이의 용도
CA2694362A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
BRPI0815038A2 (pt) * 2007-08-02 2015-03-17 Hoffmann La Roche Uso de derivados de benzamida para o tratamento de transtornos do cns
CN101784515A (zh) * 2007-08-03 2010-07-21 弗·哈夫曼-拉罗切有限公司 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物
BRPI0916363A2 (pt) * 2008-07-24 2018-05-29 Hoffmann La Roche derivados de 4,5-di-hidro-oxazol-2-ila
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
WO2013137371A1 (ja) * 2012-03-15 2013-09-19 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
CR20180443A (es) 2016-03-17 2018-11-21 Hoffmann La Roche Derivado de morfolina

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL259617A (Direct) * 1960-01-01
US3115525A (en) * 1960-04-21 1963-12-24 Wassermann S P A Soc It Per Sp Halogen-substituted amidoximes
US3394181A (en) * 1964-06-29 1968-07-23 Sterling Drug Inc Phenoxy-lower-alkyl-amidoximes and phenylamino-lower-alkyl-amidoximes
US3445517A (en) * 1966-06-03 1969-05-20 Lilly Co Eli Aryl acetamidines
FR2036958A6 (Direct) * 1969-04-23 1970-12-31 Orsymonde
FR2149264B1 (Direct) * 1971-08-13 1974-09-06 Orsymonde
US3775478A (en) * 1972-05-30 1973-11-27 Dow Chemical Co Substituted phenylthioamidines
FR2207706B1 (Direct) * 1972-11-24 1975-11-28 Orsymonde
US3939912A (en) * 1975-03-21 1976-02-24 Continental Oil Company Method for reducing the production of water from oil wells

Also Published As

Publication number Publication date
FR2338927A1 (fr) 1977-08-19
DE2702119A1 (de) 1977-07-28
DE2702119C2 (de) 1986-07-10
US4146647A (en) 1979-03-27
CA1074797A (en) 1980-04-01
JPS52105131A (en) 1977-09-03
IE44416B1 (en) 1981-11-18
CH620901A5 (Direct) 1980-12-31
FR2338927B1 (Direct) 1980-10-10
NL7700806A (nl) 1977-07-28
SE440501B (sv) 1985-08-05
BE850723A (fr) 1977-05-16
SE7700777L (sv) 1977-07-27
LU76641A1 (Direct) 1977-06-24
DK30277A (da) 1977-07-27
IE44416L (en) 1977-07-26
JPS5953895B2 (ja) 1984-12-27
GB1538097A (en) 1979-01-10
NL188573C (nl) 1992-08-03

Similar Documents

Publication Publication Date Title
ES455294A1 (es) Un procedimiento de preparacion de una fenilamidina sustituida.
BG30015A3 (bg) Метод за получаване на трифенилалкенови производни
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG31946A4 (bg) Метод за получаване на 4-ациламино-фенил- етаноламини
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG34908A3 (bg) Метод за получаване на d- 6- n- пропилерголини
BG31649A3 (bg) Метод за получаване на нитросъединения
ES462422A1 (es) Procedimiento para la preparacion de compuestos derivados den-alquil-sulfo-noxi-acetil-anilinas.
BG28849A3 (bg) Метод за получаване на гамапирони
BG32853A3 (bg) Метод за получаване на 1- оксадетиацефалоспорини
BG28056A3 (bg) Метод за получаване на 5-амино-1,2,3-тиадиазол
BG28054A3 (bg) Метод за получаване на 2-(4-ароил-пиперазин-1-ил)-4-амино-6,7- диметоксихиназолини
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
ES454824A1 (es) Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina.
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG35045A3 (bg) Метод за получаване на заместени триарилтиазолови съединения
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
BG28062A3 (en) Method of obtaining of 6a,10a, cishexahydrodibenzopyranones
ES465761A1 (es) Procedimiento para la obtencion de compuestos de acido 3-ha-logenosulfonil-tiofen-carboxilico.
BG34905A3 (bg) Метод за получаване на d- диамониева сол на окиса- бета- лактам
JPS5293771A (en) Benzotriazoles
ES451741A2 (es) Procedimiento para preparar derivados de naftiridina.
ES460297A1 (es) Un compuesto.
ES455592A1 (es) Procedimiento para la preparacion de hidrazinas.
BG32567A3 (bg) Метод за получаване на dl-6-етокси-4,5- дихидро 1н-(или 2н)-индизол

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19931113